Patients with overweight or obesity who used maridebart cafraglutide experienced significant weight loss at 1 year, according ...
Designed to transform the treatment landscape for diabetes, metabolic syndrome and weight loss, Laxxon's breakthrough oral GLP-1 agonist, LXM.2, offers a once-daily robust alternative to injections ...
14h
NEW YORK, NY / ACCESSWIRE / January 15, 2025 / Laxxon Medical, a leading pharmaceutical technology company pioneering a new generation of advanced oral drug delivery systems, today announced the succe ...
A dietetics professor explains who should and should not embrace the latest weight-loss drugs. Holiday weight gain hits home ...
When drugmakers pulled the weight-loss drug fen-phen off the market in 1997, my mom was devastated. Not because the FDA ...
I'm cautious about Novo Nordisk's short-term prospects due to the recent selloff, but see long-term potential with high ...
Drugs like Ozempic, Wegovy and Mounjaro are changing the game for weight loss according to a University of Illinois professor ...
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback